Nimbex (Cisatracurium Besilate)

Cisatracurium besilate, the active ingredient in Nimbex, is a non-depolarizing neuromuscular blocking agent presented as an injectable solution for intravenous use. It facilitates endotracheal intubation, provides muscle relaxation during surgery, and supports mechanical ventilation in intensive care settings.

GNH USA supplies Nimbex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Cisatracurium besilate, a non‑depolarizing neuromuscular blocker, is used in clinical situations requiring skeletal muscle relaxation.

- Facilitation of endotracheal intubation: provides rapid, controlled relaxation of the airway muscles to enable safe tube placement. - Muscle relaxation during surgery: maintains a relaxed skeletal musculature throughout general anesthesia for optimal surgical conditions. - Mechanical ventilation: supports prolonged ventilation by preventing patient‑initiated breaths that could interfere with ventilator synchrony.

Cisatracurium besilate may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Redness or pain at the injection site - Transient flushing or warmth sensation - Mild hypotension - Bradycardia - Histamine release causing itching

Serious or Rare Side Effects: - Prolonged neuromuscular blockade leading to respiratory failure - Anaphylactic reaction with airway edema - Hyperkalemia in susceptible patients

When using cisatracurium besilate, clinicians should observe specific safety measures to minimise risks.

- Patient monitoring: continuous neuromuscular function monitoring is required during infusion. - Dose adjustment: reduce dose in patients with severe hepatic or renal impairment due to altered elimination. - Histamine sensitivity: avoid rapid bolus in patients with known histamine‑mediated disorders. - Concomitant neuromuscular blockers: avoid simultaneous use with other depolarizing agents to prevent additive blockade. - Pregnancy and lactation: use only if benefit outweighs potential risk, as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Cisatracurium besilate can interact with other medications that affect neuromuscular transmission or histamine release.

Major Interactions (Avoid): - Aminoglycoside antibiotics (e.g., gentamicin): potentiate neuromuscular blockade, increasing risk of prolonged paralysis. - Volatile anesthetics (e.g., sevoflurane): synergistic effect on muscle relaxation, may require dose reduction.

Moderate Interactions (Monitor Closely): - Magnesium sulfate: enhances blockade, monitor neuromuscular function. - Lithium therapy: may increase sensitivity to neuromuscular blockers. - Calcium channel blockers: can modestly augment blockade, observe patient response.